Medicare Coverage Center
- Lower Limb Prosthetic Workgroup Consensus Document
- What's New - Opens in a new window
- ICD-10
- Coverage with Evidence Development
- Medicare Coverage Database - Opens in a new window
- Medicare Coverage Related to Investigational Device Exemption (IDE) Studies
- NCAs - Opens in a new window
- NCDs - Opens in a new window
- Index of MEDCAC Meetings - Opens in a new window
- Index of Technology Assessments - Opens in a new window
- Lab NCDs - ICD-10
- Public Comments
Important Links
Coverage Process
- Medicare Coverage Determination Process
- How to Request an NCD
- Local Coverage Determinations
- Medicare Evidence Development & Coverage Advisory Committee
- Potential NCD Topics
Information Exchange
Coverage Database
- Search - Opens in a new window
- Indexes - Opens in a new window
- Reports - Opens in a new window
- Downloads - Opens in a new window
Coverage Guidance Documents
- Medicare Coverage Guidance Documents
- Guidance for the Public, Industry, and CMS Staff: Coverage with Evidence Development
- Factors CMS Considers in Commissioning External Technology Assessments - Opens in a new window
- Factors CMS Considers in Referring Topics to the Medicare Evidence Development and Coverage Advisory Committee - Opens in a new window
Other Coverage Issues
- Medicare Coverage - General Information
- Medicare Coverage Related to Investigational Device Exemption (IDE) Studies
- ICD-10
- CMS/FDA Memo of Understanding - Opens in a new window
- CDC Framework for Patient-Centered Health Risk Assessment - Opens in a new window
- Compendia 1861 (t)(2) - Anti-cancer
- Lab NCDs - ICD-9
- Lab NCDs - ICD-10
- Medicare Clinical Trial Policies
- Erythropoietin Stimulating Agents Policies
Related Instructions
Coverage with Evidence Development (CED)
- Coverage With Evidence Development
- Allogeneic Hematopoietic Stem Cell Transplant for MDS
- Allogeneic Hematopoietic Stem Cell Transplant for Multiple Myeloma
- Allogeneic Hematopoietic Stem Cell Transplant for Myelofibrosis
- Allogeneic Hematopoietic Stem Cell Transplant for Sickle Cell Disease
- Amyloid PET
- Artificial Hearts
- Autologous Platelet-rich Plasma
- Cochlear Implantation
- CPAP For Obstructive Sleep Apnea
- Extracorporeal Photopheresis for Bronchiolitis Obliterans Syndrome Following Lung Transplant
- FDG PET and Other Neuroimaging Devices for Dementia
- Home Oxygen for COPD
- Home Use of Oxygen to Treat Cluster Headache
- Leadless Pacemakers
- Magnetic Resonance Angiography and Magnetic Resonance Imaging
- NaF-18 PET for Bone Metastasis
- Off-label use of Colorectal Cancer Drugs
- Percutaneous Image-guided Lumbar Decompression for Lumbar Spinal Stenosis
- Percutaneous Left Atrial Appendage Closure (LAAC)
- Pharmacogenomic Testing for Warfarin Response
- TENS for chronic low back pain
- Transcatheter Aortic Valve Replacement
- Transcatheter Mitral Valve Repair
Facilities/Trials/Registries
- Medicare Approved Facilities/Trials/Registries
- Carotid Artery Stenting Facilities
- Carotid Artery Stenting Facility Recertification Process
- Carotid Artery Stenting (CAS) Investigational Studies
- ICD Registry
- Intensive Cardiac Rehabilitation (ICR) Programs
- Long Term Oxygen Treatment Trial
- Lung Cancer Screening Registries
- Lung Volume Reduction Surgery (LVRS)
- National Oncologic PET Registry (NOPR)
- PET for Dementia Trials
- VAD Destination Therapy Facilities
